Professor Michael Zitzmann
We also know hematocrit can be increased by testosterone preparations. It depends on the preparation, and we think that there is data that shows that the threshold of 52-54% should not be surpassed, and men should be controlled for the hematocrit especially in the...
https://www.androgensociety.org/newsletter/death-by-testosterone
In July 2023 the cardiovascular results of the TRAVERSE trial were published in the New England Journal of Medicine, demonstrating conclusively that the use of testosterone therapy (TTh) in T-deficient men was associated with no...